Eli Lilly and Company $LLY, a renowned pharmaceutical corporation, has announced a significant issuance of six series of bonds totaling $6.5 billion. This issuance, referred to as "Notes," covers maturities from 2028 to 2065, reflecting the company's long-term strategic planning and a high level of confidence in its financial stability.